Metastatic Melanoma: ASCO Tumor Boards

Product ID : MMTB17
Price: $15.00
You will receive a link to your product from customerservice@asco.org within 1 hour of purchase confirmation. Shipping charges do not apply to digital products.
E-mail to a friend

Purchase

Description

This is a case-based activity that includes discussion of 73 year-old man with no other medical problems. Past medical history includes a 1.15 mm ulcerated melanoma, 3 mit/mm2 Left post shoulder in May 2012. Wide local excision/sentinel lymph node revealed no residual melanoma in wide local excision and 0/2 lymph nodes. No adjuvant therapy was recommended. In September 2016, new lesion noted R chest, 25 mm, firm subcutaneous nodule. Biopsy revealed metastatic melanoma.

 Learning Objectives:

  • Discuss the initial treatment selection for patients with rapidly progressive melanoma
  • Manage steroid refractory diarrhea resulting from checkpoint blockade
  • Describe the persistent nature of some of the autoimmune averse events associated with checkpoint blockade
  • Explain the role of surgical management of oligo-metastatic disease

 

IMPORTANT NOTE: This course expires on September 27, 2020. Participants must complete all necessary course components by this date.

 

Purchase the 2017 ASCO Tumor Boards Bundle to access to all 2017 ASCO Tumor Boards for added savings. Purchased separately, these items would be $180 altogether. When bundled, you save $55.